Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 133
Appendix A
Committee Member Biographies
Roderick J. Flower, Ph.D., D.Sc., FMedSci, FBPharmacolS, FRS (Chair)
is professor of biochemical pharmacology at the William Harvey Research
lnstitute, Barts, and The London School of Medicine and Dentistry. Dr.
Flower received his postgraduate training at the Department of Pharma -
cology in the Royal College of Surgeons of England under the supervision
of Sir John Vane. He moved with Vane when the latter became research
and development (R&D) director at the Wellcome Foundation in Kent
and worked there as part of his prostaglandin research team until 1984.
Dr. Flower then served as chair of pharmacology at the University of
Bath, where he also served as head of the School of Pharmacy and Phar-
macology (1987-1989). ln 1989, he moved to the medical college of St.
Bartholomew’s Hospital, where he became a director and founding mem-
ber of the William Harvey Research lnstitute and started a new Depart-
ment of Biochemical Pharmacology. He served as head of the institute
(1998-2002) and was also Wellcome Principal Research Fellow (1994-2007).
His main interests are the mechanism of action of anti-inflammatory
drugs including Cox inhibitors and glucocorticoid steroids. Dr. Flower
has published more than 300 peer-reviewed research papers and holds
several patents. He has trained numerous Ph.D. students, hosted many
researchers from overseas in his group, and made important contribu-
tions to undergraduate teaching. He has served on several editorial and
scientific boards and was president of the British Pharmacological Society
(2000-2003). Dr. Flower’s honors include the Thomas Woodcock Physiol -
ogy Prize (University of Sheffield, 1972), British Pharmacological Society’s
Sandoz Prize (1978), Gaddum Memorial Lecture and Medal of The British
133
OCR for page 134
134 APPENDIX A
Pharmacological Society (1986), Fellow of the Academy of Medical Sci -
ences (1999), Fellow of Academia Europeae (2001), William Withering
Medal of the Royal College of Physicians (2003), Lifetime Achievement
Award of the lnternational Society of lnflammation Associations (2005),
and Bayliss-starling Prize Lecture of the Physiological Society (2006). He
was elected a Fellow of the Royal Society in 2003. Dr. Flower served on the
NRC Committee for the lnternational Outreach Activities on Biosecurity:
A Workshop on Building Bridges Between the Scientific and Policy Com-
munities and also on the organizing committee for a 2006 Royal Society-
lAP-ICSU workshop on developments in the life sciences and potential
implications for the Biological and Toxin Weapons Convention.
Hernan Chaimovich, Ph.D. is a professor in the Department of Biochem-
istry of the lnstitute of Chemistry, Universidade de Säo Paulo, Brazil,
and superintendent general of the Butantan Foundation. He received
a degree in biochemistry from the Universidad de Chile, worked with
Osvaldo Cori in apyrase enzymology, and spent 2.5 years in the United
States working under the supervision of C. A. Bunton (University of
California, Santa Barbara) and F. H. Westheimer (Harvard University) in
physical organic chemistry. He returned to Chile as an assistant professor
of biochemistry and moved to Brazil in 1969, first as a FAPESP fellow in
the Department of Physiology at the Faculty of Medicine, Universidade
de São Paulo (USP) and later in the Department of Biochemistry of the
lnstitute of Chemistry, USP, where he became a full professor in 1985. Dr.
Chaimovich’s research is in interfacial effects on chemical and biological
reactivity using micelles and vesicles as models. The contributions of
his group, including theoretical and experimental studies of the effect of
micelles and vesicles on a number of chemical reactions, have contrib -
uted to dissect the effect of these aggregates on chemical reactivity. Dr.
Chaimovich is a co-chair of the lnterAmerican Network of Academies
of Sciences (IANAS) and is a full member of the Brazilian Academy of
Sciences and the Academy of Sciences of Latin America (ACAL). He is
also a fellow of the Third World Academy of Sciences (TWAS) and of the
American Association for the Advancement of Science (AAAS), being
a corresponding member of the Chilean Academy of Sciences. He has
received several prizes, including the Grand-Cross of the National Order
of Scientific and Technological Merit, the highest scientific distinction
conceded by the Brazilian government. Dr. Chaimovich has also recently
served as vice-president for external relations for the lnternational Coun-
cil for Science (ICSU) and has encouraged its unions to become engaged
in biosecurity issues.
Nancy D. Connell, Ph.D. is a professor of infectious disease at the Univer-
sity of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medi-
OCR for page 135
135
APPENDIX A
cal School and director of the UMDNJ Center for BioDefense and the Bio -
safety Level 3 Facility of UMDNJ’s Center for the Study of Emerging and
Re-emerging Pathogens. She chairs the university’s Institutional Biosafety
Committee, and she has worked with several international programs on
dual use issues. She is past chair of the National Institutes of Health’s
Center for Scientific Review Study Section HIBP (Host Interactions with
Bacterial Pathogens), which reviews bacterial-pathogenesis submissions
to the National Institute of Allergy and Infectious Diseases. She is current
chair of the F13 Infectious Diseases and Microbiology Fellowship Panel.
Dr. Connell’s involvement in biological weapons control began in 1984,
when she was chair of the Committee on the Military Use of Biological
Research, a subcommittee of the Council for Responsible Genetics, based
in Cambridge, Massachusetts. Dr. Connell received her Ph.D. in microbial
genetics from Harvard University. Her major research focus is in bacterial
antibiotic drug discovery.
Andrzej Górski, M.D., Ph.D. is professor of medicine and immunology
at the Medical University of Warsaw and vice president of the Polish
Academy of Sciences. He is board certified in internal medicine with
a subspecialty certification in clinical immunology. Dr. Górski received
his M.D. (1970) and Ph.D. (1973) degrees from the Medical University
of Warsaw and was a Fulbright Scholar at the Sloan-Kettering Institute
for Cancer Research, USA. He has been a visiting professor at Adelaide
Children’s Hospital, Australia, the Weizmann Institute of Science, Israel,
the University of London United Medical and Dental Schools of Guy’s
and St. Thomas’s Hospitals, England, and the Universidad Autonoma,
Madrid, Spain. Dr. Górski served as prorector for scientific affairs &
international cooperation (1993-1996) and as rector (1996-1999) of the
Medical University of Warsaw. From 1999-2007 he was also director of
the L. Hirszfeld Institute of Immunology and Experimental Therapy at
the Polish Academy of Sciences. Dr. Górski has authored more than 100
scientific publications, serves as the editor in chief of Archivum Immunolo-
giae et Therapiae Experimentalis, and has served as a member of the edito-
rial board of Science & Engineering Ethics. His awards include the Meller
Award for excellence in cancer research from Sloan-Kettering Institute, the
ICRETT Award and the Yamagiwa-Yoshida Award from the International
Union Against Cancer, the J. Sniadecki Memorial Award from the Polish
Academy of Sciences (the highest award in medical sciences in Poland),
and the Gloria Medicinae awarded by the Polish Medical Association. In
addition, Dr. Górski is a member of the Committee for Ethics in Science
at the Polish Academy of Sciences, a member of the Committee for Ethics
in Science at the Ministry of Science, Head of the Bioethics Committee,
Ministry of Health, and represents Poland in the Forum of National Ethics
Committees to the European Commission.
OCR for page 136
136 APPENDIX A
Li Huang, Ph.D. received his Ph.D. in the Department of Microbiology
at the University of Guelph, Ontario, Canada, in 1988. He was a postdoc -
toral fellow in the Department of Biochemistry of the School of Hygiene
and Public Health at the Johns Hopkins University, Maryland, from 1988
to 1993. He became assistant professor in the Department of Biology
at Pomona College, California, in 1993 before joining the faculty in the
Institute of Microbiology, Chinese Academy of Sciences, in 1996. He was
appointed to full professorship in 1998 and is now director-general of
the Institute of Microbiology, Chinese Academy of Sciences. Dr. Huang’s
scientific work concerns the isolation and biotechnological exploitation
of microorganisms and their genes from various environments. He has
also been working on biosecurity-related issues since 2001, and he is cur-
rently a member of the Biosecurity Working Group of the InterAcademy
Panel (IAP).
Maxwell Otim Onapa, Ph.D., M.Sc. is the deputy executive secretary
of the Uganda National Council for Science and Technology (UNCST),
where he has been stationed since 2006. His responsibilities include pro -
viding leadership and technical support in the design, development, and
implementation of programs and projects. He also served as chair of
the Uganda National Academy of Sciences’ Committee on Assessing the
Current State of Knowledge Pertaining to the Meaning and Scope of
Biosafety and Biosecurity in the Context of Uganda, which published the
report, The Scope of Biosafety and Biosecurity in Uganda: Policy Recommenda-
tions for the Control of Associated Risks (2010). Previously, Dr. Otim Onapa
worked at the National Agricultural Research Organisation (NARO) as
a research officer, infectious disease, Livestock Health Research Institute
(2000-2006) and as a research assistant (1994-1999). From 1992 to 1994, he
had worked as a veterinary research officer, microbiology, Animal Health
Research Centre, Entebbe. Academically, Dr. Otim Onapa has a Ph.D. from
the Royal Veterinary and Agricultural University, Copenhagen; an M.Sc.
(Tropical Veterinary Epidemiology) from the Free University of Berlin/
Addis Ababa University; and a Bachelor of Veterinary Medicine (BVM)
from Makerere University, Uganda. Dr. Otim Onapa has published widely
and has had additional professional training in various areas including
strategic management, molecular diagnostic polymerase chain reaction
training, laboratory diagnosis of avian influenza, among others. He has
also presented as a member of papers on biosafety and biosecurity in dif -
ferent international forums.
M. Iqbal Parker, Ph.D. received his B.Sc. in biochemistry and microbiol-
ogy in 1974, his B.Sc. (Honors) in 1975, and his Ph.D. in biochemistry in
1979 from the University of Cape Town. Dr. Parker is currently director of
the Cape Town component of the International Center for Genetic Engi -
OCR for page 137
137
APPENDIX A
neering and Biotechnology (ICGEB), professor in medical biochemistry at
the University of Cape Town, and director of the South African Medical
Research Council’s Oesophageal Cancer Research Group based at the
University of Cape Town. Before taking up the post with the ICGEB, he
was director of the School of Biomedical Sciences and head of the Divi -
sion of Medical Biochemistry at the University of Cape Town and subse -
quently, the deputy dean for research in the Health Science Faculty. Dr.
Parker is past-president of the South African Society for Biochemistry and
Molecular Biology and was a key member in founding of the Federation
African Societies on Biochemistry and Molecular Biology and is currently
its treasurer. He has been elected onto the IUBMB Executive Committee
on Symposia and also the Chair of the Wood-Whelan Fellowship Commit-
tee. He is a founding member, current secretary general, and chair of the
Biosafety Committee of the South African Academy of Sciences.
Andrew Pitt, D. Phil. is chair of Pharmaceutical Chemistry and Chemi-
cal Biology, School of Health and Life Sciences at Ashton University in
Birmingham, United Kingdom. Until 2011 he was reader and director of
the Sir Henry Wellcome Functional Genomics Facility (SHWFGF) at the
University of Glasgow. He also served as director of the Doctoral Training
Centre in Proteomics and as managing director of the RASOR Interdisci -
plinary Research Collaboration in Proteomic Technologies, which brings
together engineers, physical scientists, and biologists across the Univer-
sities of Glasgow, Dundee, Edinburgh, and Strathclyde. Dr. Pitt’s multi-
disciplinary research involves proteomics, protein science, post-genomics
technologies, biochemistry, biomolecular analysis, and systems and syn -
thetic biology. His research focuses particularly on the generation of new
technologies for modern protein research, biomarker discovery and iden-
tification, complex biochemical pathways and molecular networks, inte-
gration and modeling for systems biology, and clinical applications of
proteomics. He is a member of the Royal Society Standing Committee on
Scientific Aspects of International Security (2007-present), a member of the
Executive Board of the British Society for Proteome Research (2007-present),
and a member of the editorial board of the Journal of Proteomics.
Ralf Trapp, Ph.D. is an independent consultant who has worked and
published extensively in the fields of chemical and biological weapons
disarmament and nonproliferation. His research includes the impact of
advances in science and technology on the regimes pertaining to chemi -
cal and biological weapons, national implementation measures for the
Chemical Weapons Convention and the Biological Weapons Convention
(such as legislation, regulations, training, enforcement, self-regulation
in industry and academia, oversight, and education), and other aspects
of preparedness and consequence management. He formerly served as
OCR for page 138
138 APPENDIX A
secretary of the Scientific Advisory Board of the Organization for the Pro-
hibition of Chemical Weapons (1998-2006), which administers the Chemi -
cal Weapons Convention. He also served as legal coordinator (consultant)
for the European Union Joint Action in Support of the Biological and
Toxin Weapons Convention (2007-2008), which was executed by the Bio-
Weapons Prevention Project, Geneva, Switzerland. Dr Trapp is an external
member of the Academy of Sciences of Bologna and a fellow of the Inter-
national Union of Pure and Applied Chemistry (IUPAC). He received his
Dr. rer. nat. (Ph.D.) from the Technical University “Carl Schorlemmer”
Leuna-Merseburg (former German Democratic Republic) in 1978 and Dr.
sc. nat. from the GDR Academy of Sciences, Leipzig, in 1986.
Lloyd Whitman, Ph.D., M.S. joined the Center for Nanoscale Science and
Technology at the National Institute of Standards and Technology (NIST)
as the deputy director in April 2008. He received a B.S. in physics from
Brown University (with honors, magna cum laude) and M.S. and Ph.D.
degrees in physics from Cornell University. After a National Research
Council Postdoctoral Research Fellowship at NIST, he joined the research
staff at the Naval Research Laboratory (NRL). At NRL, Dr. Whitman was
most recently the head of the Surface Nanoscience and Sensor Technol -
ogy Section, a multidisciplinary research group working at the nexus of
nanoscience, biotechnology, and microsystems. He led a diverse portfolio
of research studying semiconductor, organic, and biomolecular nanostruc-
tures, their use in novel functional surfaces, and their integration into
advanced sensor systems for national security applications. In addition to
leading research at NRL, Dr. Whitman served as a science advisor to the
Special Assistant to the Secretary of Defense for Chemical and Biological
Defense and Chemical Demilitarization Programs. In this capacity, he
represented the Department of Defense on the National Science and Tech-
nology Council, Committee on Technology Subcommittee on Nanoscale
Science, Engineering and Technology. Dr. Whitman has more than 140
publications and patent applications in the areas of nanoscience and sen-
sor technology, and numerous media citations and awards, including the
Navy Meritorious Civilian Service Award.
